A Study at Multiple Centers to Evaluate the Safety and Practicality of the Levita Magnetic Surgical System for Use in Laparoscopic Upper Gastrointestinal Surgeries.
Prospective, Multicenter, Single-arm, Open-label Study to Assess the Safety and Feasibility of the Levita Magnetic Surgical System for Reduced Port in Upper Gastrointestinal Laparoscopic Procedures
1 other identifier
interventional
30
1 country
2
Brief Summary
A Study at Multiple Centers to Evaluate the Safety and Practicality of the Levita Magnetic Surgical System for Use in Laparoscopic Upper Gastrointestinal Surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2025
CompletedFirst Posted
Study publicly available on registry
December 19, 2025
CompletedStudy Start
First participant enrolled
March 30, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 5, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 12, 2026
CompletedJuly 13, 2026
July 1, 2026
1 month
December 12, 2025
July 9, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Number of Participants with Device and/or Procedure Related Adverse Events
Adverse events will be summarized by relatedness to the device and/or procedure, seriousness and level of severity.
From enrollment to end of follow up at 30 days.
Average Number of Ports
Ability to adequately retract the stomach, omentum, and small bowel to achieve effective exposure of the target tissue. Adequate retraction will be deemed to be achieved if an additional port that is typically used for retraction and exposure of target tissues can be eliminated.
During index procedure.
Study Arms (1)
Magnetic Surgical System in laparoscopic upper gastrointestinal procedures
EXPERIMENTALInterventions
The Magnetic Surgical System (MSS), which was cleared for market in the U.S. most recently per 510(k) K252435 and is commercially available in Chile, is composed of two hand-held instruments: a Magnetic Grasper and an external Magnetic Controller. The Magnetic Grasper is comprised of two main components: a detachable Grasper Tip and a Shaft. The detachable Grasper Tip provided with the Magnetic Grasper is 6.5cm in length. An optional 12.5cm length detachable Grasper Tip may be used as a replacement for the 6.5cm Grasper Tip and can be used with the Shaft interchangeably. The Magnetic Controller is a single unit with handles that is held external to the body and emits a magnetic field that attracts the detachable Grasper Tip. In this study the 6.5 Grasper Tip will be used.
Eligibility Criteria
You may qualify if:
- BMI range of 20 to 60kg/m2
- Scheduled to undergo laparoscopic procedures
- Willing and able to provide a written Informed Consent Form (ICF) to participate in the study prior to any study- required procedures
You may not qualify if:
- Individuals with pacemakers, defibrillators, or other electromedical implants
- Individuals with ferromagnetic implants
- American Society of Anesthesiologists (ASA) score of III or IV
- Significant comorbidities: cardiovascular, neuromuscular, chronic obstructive pulmonary disease, and urological disease (renal failure)
- Clinical history of impaired coagulation confirmed by abnormal blood tests
- Individuals who have signs of hepatic abnormality (e.g.: cirrhosis, liver failure, increase in liver enzymes, etc.)
- Anatomical abnormality or disease of intended target tissue noted after initiation of index procedure that would prevent device use
- Pregnant or wishes to become pregnant during the length of study participation
- Individual is not likely to comply with the follow-up evaluation schedule
- Participating in a clinical trial of another investigational drug or device
- Prisoner or under incarceration
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Levita Magneticslead
Study Sites (2)
Clinica Colonial
Huechuraba, Santiago Metropolitan, 8580645, Chile
Hospital Luis Tisne
Peñalolén, Santiago Metropolitan, 7930124, Chile
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 12, 2025
First Posted
December 19, 2025
Study Start
March 30, 2026
Primary Completion
May 5, 2026
Study Completion
June 12, 2026
Last Updated
July 13, 2026
Record last verified: 2026-07